ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 240 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2023. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,565,108 | +31.6% | 156,104 | +70.3% | 0.45% | +18.9% |
| Q2 2023 | $4,229,567 | +204.9% | 91,688 | +165.1% | 0.38% | +145.8% |
| Q1 2023 | $1,387,099 | -19.0% | 34,591 | -6.4% | 0.15% | -20.7% |
| Q4 2022 | $1,712,496 | +3.1% | 36,963 | -7.9% | 0.19% | +18.4% |
| Q3 2022 | $1,661,000 | -68.3% | 40,114 | -51.2% | 0.16% | -67.0% |
| Q2 2022 | $5,245,000 | -17.8% | 82,206 | -6.4% | 0.49% | +5.6% |
| Q1 2022 | $6,379,000 | -36.8% | 87,837 | -26.8% | 0.47% | -27.4% |
| Q4 2021 | $10,090,000 | -16.7% | 119,993 | -10.7% | 0.64% | -18.0% |
| Q3 2021 | $12,118,000 | -25.7% | 134,357 | -21.4% | 0.79% | -26.9% |
| Q2 2021 | $16,304,000 | -6.0% | 170,996 | +12.3% | 1.08% | -13.8% |
| Q1 2021 | $17,344,000 | +126.4% | 152,326 | +175.3% | 1.25% | +118.5% |
| Q4 2020 | $7,660,000 | +97.1% | 55,336 | +22.0% | 0.57% | +65.8% |
| Q3 2020 | $3,887,000 | +17.3% | 45,346 | +7.1% | 0.34% | +3.9% |
| Q2 2020 | $3,313,000 | +159.2% | 42,349 | +47.2% | 0.33% | +100.0% |
| Q1 2020 | $1,278,000 | – | 28,765 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |